MENU
+Compare
NIVF
Stock ticker: NASDAQ
AS OF
Aug 11, 02:39 PM (EDT)
Price
$1.79
Change
-$0.08 (-4.28%)
Capitalization
3.43M

NIVF NewGenIvf Group Limited Forecast, Technical & Fundamental Analysis

NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services... Show more

NIVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NIVF with price predictions
Aug 08, 2025

NIVF in -17.41% downward trend, declining for three consecutive days on August 07, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NIVF declined for three days, in of 118 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for NIVF entered a downward trend on August 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NIVF advanced for three days, in of 38 cases, the price rose further within the following month. The odds of a continued upward trend are .

NIVF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.933) is normal, around the industry mean (6.623). P/E Ratio (1.365) is within average values for comparable stocks, (118.608). NIVF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.029). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.008) is also within normal values, averaging (1.994).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NIVF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NIVF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

View a ticker or compare two or three
NIVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry HospitalNursingManagement

Profile
Fundamentals
Details
Industry
N/A
Address
Sukhumvit 21 Road, Asoke
Phone
+66 32362650
Employees
70
Web
https://www.newgenivf.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SENS0.500.03
+7.02%
Senseonics Holdings
MAN40.481.05
+2.66%
ManpowerGroup
GRI1.260.01
+0.80%
GRI Bio Inc.
DIT109.380.06
+0.05%
AMCON Distributing Co
MBLY13.60-0.38
-2.72%
Mobileye Global

NIVF and Stocks

Correlation & Price change

A.I.dvisor tells us that NIVF and AUNA have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NIVF and AUNA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NIVF
1D Price
Change %
NIVF100%
+1.08%
AUNA - NIVF
11%
Poorly correlated
-1.11%
BTMD - NIVF
7%
Poorly correlated
-1.37%
SRXH - NIVF
5%
Poorly correlated
-8.88%
PACS - NIVF
4%
Poorly correlated
+0.45%
EHAB - NIVF
3%
Poorly correlated
-2.31%
More

Groups containing NIVF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NIVF
1D Price
Change %
NIVF100%
+1.08%
Hospital/Nursing Management
industry (90 stocks)
67%
Closely correlated
+2.53%
Health Services
industry (442 stocks)
34%
Loosely correlated
+0.88%